Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Richard Aldrich Insider Profile
11 Followers
Richard Aldrich, Director at Tempest Therapeutics, holds 0.00 shares in Concert Pharma (Ticker: CNCE), holds 136.85K shares in Tempest Therapeutics (Ticker: TPST), holds ― shares in KalVista Pharmaceuticals (Ticker: KALV).
Profitable Transactions
3 out of 17 Profitable Transactions
Average Return
-31.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard Aldrich holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Mar 11, 2014 - Mar 11, 2015
Return:+347.50%
The most profitable trade made by Richard Aldrich
Richard Aldrich's Trading History
Tempest Therapeutics
Dec 11, 2018
Director
Uninformative Buy
―
$122.21K
KalVista Pharmaceuticals
Oct 19, 2017
Director
Informative Buy
4.87M
―
Concert Pharma
Mar 06, 2023
―
Uninformative Sell
―
$0.00
PTC Therapeutics
Jun 10, 2015
Director
Uninformative Sell
389.59K
$0.00
Verastem
May 20, 2014
Director
Informative Buy
8.37K
$2.78M
Epirus Biopharma
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Richard Aldrich's performance on stock
You May Also Like
Richard Aldrich insider profile FAQ
What is the percentage of profitable transactions made by Richard Aldrich?
The percentage of profitable transactions made by Richard Aldrich is 18%.
What is the average return per transaction made by Richard Aldrich?
The average return per transaction made by Richard Aldrich is -31.90%.
What stocks does Richard Aldrich hold?
Richard Aldrich holds: TPST, KALV, CNCE, PTCT, VSTM, EPRSQ stocks.
What was Richard Aldrich’s latest transaction?
Richard Aldrich latest transaction was an Uninformative Sell of ―.
What was Richard Aldrich's most profitable transaction?
Richard Aldrich’s most profitable transaction was an Informative Buy of TPST stock on March 11, 2014. The return on the trade was 347.50%.
What is Richard Aldrich's role in Tempest Therapeutics?
Richard Aldrich's role in Tempest Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.